292 related articles for article (PubMed ID: 29062359)
1. Recovery from severe dysphagia in systemic sclerosis - myositis overlap: a case report.
Chinniah KJ; Mody GM
Afr Health Sci; 2017 Jun; 17(2):593-596. PubMed ID: 29062359
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis.
Giannini M; Fiorella ML; Tampoia M; Girolamo F; Fornaro M; Amati A; Lia A; Abbracciavento L; D'Abbicco D; Iannone F
Rheumatology (Oxford); 2021 Mar; 60(3):1234-1242. PubMed ID: 32911543
[TBL] [Abstract][Full Text] [Related]
3. MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report.
Alqatari S; Riddell P; Harney S; Henry M; Murphy G
BMC Pulm Med; 2018 Apr; 18(1):59. PubMed ID: 29665800
[TBL] [Abstract][Full Text] [Related]
4. Recurrent spontaneous subdural hematoma secondary to immune thrombocytopenia in a patient with overlap syndrome.
Goh KG; Ong SG
Lupus; 2015 Jan; 24(1):90-3. PubMed ID: 25305213
[TBL] [Abstract][Full Text] [Related]
5. Effect of Sequential Intravenous Pulse Cyclophosphamide-Azathioprine in Systemic Sclerosis-Interstitial Lung Disease: An Open-Label Study.
Kundu S; Paul S; Hariprasath K; Agarwal R; Ghosh S; Biswas D
Indian J Chest Dis Allied Sci; 2016; 58(1):7-10. PubMed ID: 28368564
[TBL] [Abstract][Full Text] [Related]
6. Are high doses of prednisone necessary for treatment of interstitial lung disease in systemic sclerosis?
Pérez Campos D; Estévez Del Toro M; Peña Casanovas A; González Rojas PP; Morales Sánchez L; Gutiérrez Rojas AR
Reumatol Clin; 2012; 8(2):58-62. PubMed ID: 22317852
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous endoscopic gastrostomy feeding--a life-saving intervention in SSc-myositis overlap with pharyngeal dysfunction.
Das L; Bowden A; Cooper RG; Mitchell W; O'Sullivan M; Herrick AL
Rheumatology (Oxford); 2012 Aug; 51(8):1518-20. PubMed ID: 22461389
[No Abstract] [Full Text] [Related]
9. Corticosteroids in Myositis and Scleroderma.
Postolova A; Chen JK; Chung L
Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease.
Rigolet A; Musset L; Dubourg O; Maisonobe T; Grenier P; Charuel JL; Behin A; Herson S; Amoura Z; Benveniste O
Medicine (Baltimore); 2012 Mar; 91(2):95-102. PubMed ID: 22391471
[TBL] [Abstract][Full Text] [Related]
11. Experience with azathioprine in systemic sclerosis associated with interstitial lung disease.
Dheda K; Lalloo UG; Cassim B; Mody GM
Clin Rheumatol; 2004 Aug; 23(4):306-9. PubMed ID: 15293090
[TBL] [Abstract][Full Text] [Related]
12. Cricopharyngeal bar and dermatomyositis: A cause of rapidly progressive dysphagia.
Adams CL; Lohan S; Bruce A; Kamalaraj N; Gunaratne S; White R
Int J Rheum Dis; 2021 Jan; 24(1):125-131. PubMed ID: 33135370
[TBL] [Abstract][Full Text] [Related]
13. Difficult case: rituximab in anti-SRP antibody myositis in pregnancy.
Mehta P; Dorsey-Campbell R; Dassan P; Nelson-Piercy C; Viegas S
Pract Neurol; 2019 Oct; 19(5):444-446. PubMed ID: 30979789
[TBL] [Abstract][Full Text] [Related]
14. Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders.
Iudici M; Cuomo G; Vettori S; Bocchino M; Sanduzzi Zamparelli A; Cappabianca S; Valentini G
Semin Arthritis Rheum; 2015 Feb; 44(4):437-44. PubMed ID: 25282395
[TBL] [Abstract][Full Text] [Related]
15. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
[TBL] [Abstract][Full Text] [Related]
16. [Pharyngeal dysphagia and polymyositis].
Chemtob A; Malka D; Lévy P; Lévy H; Ponsot P; Bernades P
Gastroenterol Clin Biol; 1993; 17(6-7):502-4. PubMed ID: 8243939
[TBL] [Abstract][Full Text] [Related]
17. [Cyclophosphamide pulse therapy for pediatric systemic sclerosis].
Iwata N; Miyamae T; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S; Kondo M; Sasaki T; Ikezawa Y
Ryumachi; 2003 Oct; 43(4):660-6. PubMed ID: 14598659
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
[TBL] [Abstract][Full Text] [Related]
19. Dermatomyositis and polymyositis: clinical aspects.
Kagen LJ
Clin Exp Rheumatol; 1984; 2(3):271-7. PubMed ID: 6397283
[No Abstract] [Full Text] [Related]
20. Immunosuppressive drug therapy.
McCune WJ; Vallance DK; Lynch JP
Curr Opin Rheumatol; 1994 May; 6(3):262-72. PubMed ID: 8060760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
